Upgrades
- According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed an EPS of $0.23, compared to $0.33 from the year-ago quarter. The current stock performance of BioCryst Pharmaceuticals shows a 52-week-high of $19.99 and a 52-week-low of $7.61. Moreover, at the end of the last trading period, the closing price was at $11.86.
- According to B of A Securities, the prior rating for KKR & Co Inc (NYSE:KKR) was changed from Neutral to Buy. In the third quarter, KKR & Co showed an EPS of $0.93, compared to $1.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $75.19 and a 52-week-low of $41.77. KKR & Co closed at $49.47 at the end of the last trading period.
- Baird upgraded the previous rating for Premier Inc (NASDAQ:PINC) from Neutral to Outperform. For the first quarter, Premier had an EPS of $0.52, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $41.42 and a 52-week-low of $31.00. Premier closed at $31.77 at the end of the last trading period.
- According to Morgan Stanley, the prior rating for Abiomed Inc (NASDAQ:ABMD) was changed from Underweight to Equal-Weight. For the second quarter, Abiomed had an EPS of $1.30, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $381.99 and a 52-week-low of $219.84. Abiomed closed at $377.82 at the end of the last trading period.
- Raymond James upgraded the previous rating for IPG Photonics Corp (NASDAQ:IPGP) from Underperform to Market Perform. In the third quarter, IPG Photonics showed an EPS of $1.47, compared to $1.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $176.63 and a 52-week-low of $79.88. IPG Photonics closed at $85.48 at the end of the last trading period.
